Immunohistochemical evaluation of microphthalmia-associated transcription factor expression in giant cell lesions

Raja R Seethala1, John R Goldblum, David G Hicks

  • 1University of Pennsylvania Medical Center, Philadelphia, PA 19104, USA. seethalr@uphs.upenn.edu

Insights

Microphthalmia-associated transcription factor (Mitf) is expressed in giant cells of various bone lesions, suggesting a role in their formation. This contrasts with osteopetrosis, where Mitf is absent, supporting mononuclear cell origin for giant cells.

Area of Science:

  • Pathology
  • Cell Biology
  • Oncology

Background:

  • Microphthalmia-associated transcription factor (Mitf) is crucial for osteoclast differentiation.
  • Dysfunctional Mitf is linked to osteopetrosis.
  • Giant cells in various tumors are traditionally considered monocyte-derived.

Purpose of the Study:

  • To investigate Mitf expression in diverse giant cell lesions.
  • To determine if Mitf differentiates monocyte-derived giant cells from other giant cell types.
  • To explore Mitf's role in the multinucleation of giant cells.

Main Methods:

  • Immunohistochemical analysis of Mitf expression using a monoclonal antibody.
  • Evaluation of 89 giant cell lesions, including giant cell tumor of bone, PVNS, and aneurysmal bone cysts.
  • Comparison with osteopetrosis and non-giant cell tissues.

Main Results:

  • Mitf was variably expressed in most giant cell lesions of presumed monocyte origin (80-100% in most).
  • No Mitf immunoreactivity was observed in osteopetrosis or non-monocyte-derived giant cells.
  • Mitf expression was rare in mononuclear cells without giant cell formation.

Conclusions:

  • Giant cells in various lesions likely originate from adjacent mononuclear cells.
  • Mitf expression supports its involvement in the multinucleation process of these cells.
  • Mitf can serve as a marker to distinguish monocyte-derived giant cells.

Related Concept Videos